Intratumoral spatial heterogeneity at non-contrast CT predicts histological grading of invasive pulmonary adenocarcinoma: a multicenter retrospective study.
1/5 보강
[OBJECTIVES] The International Association for the Study of Lung Cancer (IASLC) grading system is key to the prognosis and treatment of Invasive Pulmonary Adenocarcinoma (IPA).
- p-value p = 0.002
- p-value p = 0.083
APA
Qin S, Zhou S, et al. (2026). Intratumoral spatial heterogeneity at non-contrast CT predicts histological grading of invasive pulmonary adenocarcinoma: a multicenter retrospective study.. PloS one, 21(2), e0341163. https://doi.org/10.1371/journal.pone.0341163
MLA
Qin S, et al.. "Intratumoral spatial heterogeneity at non-contrast CT predicts histological grading of invasive pulmonary adenocarcinoma: a multicenter retrospective study.." PloS one, vol. 21, no. 2, 2026, pp. e0341163.
PMID
41628154 ↗
Abstract 한글 요약
[OBJECTIVES] The International Association for the Study of Lung Cancer (IASLC) grading system is key to the prognosis and treatment of Invasive Pulmonary Adenocarcinoma (IPA). However, current radiomics and other radiological approaches poorly capture tumor heterogeneity, limiting predictive power. This study aimed to develop an interpretable CT-based model that predicts the histological grading of IPA by decoding its intratumoral spatial heterogeneity.
[MATERIALS AND METHODS] This multi‑center retrospective study enrolled 355 IPA patients, split into training/validation (7:3) and an independent test cohort. Tumors were graded as low‑grade (Ⅰ/Ⅱ) or high‑grade (Ⅲ) per IASLC criteria. Intratumoral subregions were generated via unsupervised clustering of CT images, and their spatial interaction heterogeneity was quantified using a Multi-regional Spatial Interaction (MSI) matrix. Five models (clinical‑radiological, radiomics, MSI, radiomics‑combined, MSI‑combined) were built using four preprocessors and five classifiers. The optimal model was selected based on the Receiver Operating Characteristic (ROC) curve in the validation cohort, with generalizability assessed in the test cohort. Performance was compared via the DeLong test, and SHapley Additive exPlanations (SHAP) analysis interpreted feature contributions.
[RESULTS] Three subregions were generated. The high-grade group exhibited a larger proportion of Subregion 1, while showing a smaller proportion of Subregion 2. The MSI model based on 10 MSI features achieved an AUC of 0.806 in the test cohort, outperforming clinical‑radiological, radiomics, and radiomics‑combined models (p = 0.002, 0.010, 0.022). Adding clinical‑radiological features did not improve the MSI model (p = 0.083). SHAP identified MSI_border_proportion_2_3 (relative border proportion between Subregions 2 and 3) as the most influential feature, with lower values indicating high‑grade IPA.
[CONCLUSION] The CT-based MSI model can predict the histological grade of IPA by decoding the spatial interaction heterogeneity of different subregions in the tumor, thereby providing reliable imaging evidence for preoperative individualized risk assessment.
[MATERIALS AND METHODS] This multi‑center retrospective study enrolled 355 IPA patients, split into training/validation (7:3) and an independent test cohort. Tumors were graded as low‑grade (Ⅰ/Ⅱ) or high‑grade (Ⅲ) per IASLC criteria. Intratumoral subregions were generated via unsupervised clustering of CT images, and their spatial interaction heterogeneity was quantified using a Multi-regional Spatial Interaction (MSI) matrix. Five models (clinical‑radiological, radiomics, MSI, radiomics‑combined, MSI‑combined) were built using four preprocessors and five classifiers. The optimal model was selected based on the Receiver Operating Characteristic (ROC) curve in the validation cohort, with generalizability assessed in the test cohort. Performance was compared via the DeLong test, and SHapley Additive exPlanations (SHAP) analysis interpreted feature contributions.
[RESULTS] Three subregions were generated. The high-grade group exhibited a larger proportion of Subregion 1, while showing a smaller proportion of Subregion 2. The MSI model based on 10 MSI features achieved an AUC of 0.806 in the test cohort, outperforming clinical‑radiological, radiomics, and radiomics‑combined models (p = 0.002, 0.010, 0.022). Adding clinical‑radiological features did not improve the MSI model (p = 0.083). SHAP identified MSI_border_proportion_2_3 (relative border proportion between Subregions 2 and 3) as the most influential feature, with lower values indicating high‑grade IPA.
[CONCLUSION] The CT-based MSI model can predict the histological grade of IPA by decoding the spatial interaction heterogeneity of different subregions in the tumor, thereby providing reliable imaging evidence for preoperative individualized risk assessment.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Evaluation of T1 and T2 mapping for non-invasive assessment of HER2 and PD-L1 expression in bladder cancer.
- Heavy metal exposure and cancer risk: Findings from a Mendelian randomization study.
- First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 Study.
- A Case Report of Primary Pulmonary Lymphoepithelioma-Like Carcinoma with "Harmful" Pseudoprogression and a Pathological Complete Response (pCR) after Immunotherapy Plus Radiotherapy.
- Research progress of gut microbiota and its metabolites in polycystic ovary syndrome.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.